Study on the AGEs-reducing effects induced by test food intakes
- Conditions
- Healthy male/female adults
- Registration Number
- JPRN-UMIN000042907
- Lead Sponsor
- CPCC Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Not provided
(1) Subjects with some kind of continuous medical treatment. (2) Subjects who are now under the restriction of carbohydrate with dieting (losing some weight by exercises and meal-controlling), and/or are planning to go on a diet, during this trial. (3) All through this trial, subjects who have any difficulty in refraining from taking steadily (not less than three times a week) in the health-specific/functional/supplementary/health foods, which might affect the test results. (4) Subjects who are planning to change their lifestyle. (5) Subjects with extremely irregular eating habits. (6) Subjects having not less than once a week , restricting their mealtimes to no more than once a day, within the last three months. (7) Subjects who extremely take alcohol. (8) Pregnant, possibly pregnant, or lactating women. (9) Subjects having present/previous medical history of serious diseases in heart, liver, kidney, and/or digestive organs. (10) Subjects with drug and/or food allergies, especially in wheat, eggs and milk. (11) Subjects who are now under the other clinical tests with some kind of medicine/food, or took part in those within four weeks before this trial, or are planning to participate in those after giving informed consent to take part in this trial. (12) Subjects who donated over 200 mL of their whole blood and/or blood components within a month before this trial. (13) Males who donated over 400 mL of their whole blood within the last three months before this trial. (14) Females who donated over 400 mL of their whole blood within the last four months before this trial. (15) Males who will be collected over 1200 mL of their blood within the last twelve months before this trial. (16) Females who will be collected over 800 mL of their blood within the last twelve months before this trial. (17) Others who have been determined as ineligible for participation, according to the principal/sub investigator's opinions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Advanced glycation-end products
- Secondary Outcome Measures
Name Time Method 1. Blood sugar level on empty stomach 2. HbA1c 3. Changes in clinical test values